مباشر
FierceBiotechIndivior warns of ‘significant impact’ on R&D team after opioid use disorder drug fails phase 2FierceBiotechBMS calls time on Zymeworks collab, ending work on phase 1 cancer bispecificEndpoints NewsWhat we heard at a health tech conference in BostonPromega BlogThe Filter You Didn’t ChooseFierceBiotechLabcorp raises full-year guidance, boosted by diagnostics, lab servicesFierceBiotechLeo Pharma pays $50M for Replay and its preclinical skin disease gene therapyEndpoints NewsCVS' healthcare delivery chief eyes potential in clinical AIPharmaVoicePfizer deals extend patent life for a top-selling rare disease drugFierceBiotechBeOne signs $2B deal for option on preclinical trispecific antibody from China’s HuahuiBioWorldMFDS clears Curocell’s anbal-cel as first homegrown CAR T therapyCytiva (Google News)Rockwell Automation and Cytiva launch Figurate SCADA system to eliminate digital bottlenecks in biopharmaceutical manufacturing - Manufacturing ChemistEndpoints NewsLack of specifics on obesity pill sales hover over Lilly’s first quarter
Endpoints News ٣٠ أبريل ٢٠٢٦

Lack of specifics on obesity pill sales hover over Lilly’s first quarter

Lack of specifics on obesity pill sales hover over Lilly’s first quarter

المصدر
المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.